Ubs Oconnor LLC Icon PLC Transaction History

Ubs Oconnor LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$288.23 - $331.73 $149,879 - $172,499	520 Added 53.5%	1,492 $467,000
Q1 2024 May 15, 2024	BUY	$247.84 - $340.0 $240,900 - $330,480	972 New	972 $326,000
Q3 2023 Nov 14, 2023	SELL	$236.44 - $265.62 $969,404 - $1.09 Million	-4,100 Reduced 66.72%	2,045 $503,000
Q2 2023 Aug 14, 2023	BUY	$183.12 - $250.2 $1.13 Million - $1.54 Million	6,145 New	6,145 $1.54 Billion
Q1 2023 May 15, 2023	SELL	$193.59 - $245.33 $135,319 - $171,485	-699 Reduced 9.96%	6,318 $1.35 Million
Q4 2022 Feb 14, 2023	BUY	$173.9 - $224.8 $88,167 - $113,973	507 Added 7.79%	7,017 $0
Q3 2022 Nov 14, 2022	BUY	$183.25 - $247.5 $494,775 - $668,250	2,700 Added 70.87%	6,510 $1.2 Billion
Q2 2022 Aug 12, 2022	BUY	$197.3 - $261.32 $751,713 - $995,629	3,810 New	3,810 $825,000

644

76.8M

152K

447K

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $15.5B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.